Journal of Gynecologic Oncology

Papers
(The H4-Index of Journal of Gynecologic Oncology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines89
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity38
Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis30
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial26
Step-by-step demonstration of “sciatic-nerve-preserved beyond-LEER” in a Thiel-embalmed cadaver: a novel salvage surgery for recurrent gynecologic malignancies26
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles25
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study23
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?23
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies23
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer23
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients20
Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer19
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)16
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)15
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer15
0.17073392868042